| Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages K Labadie, T Larcher, C Joubert, A Mannioui, B Delache, P Brochard, ... The Journal of clinical investigation 120 (3), 894-906, 2010 | 657 | 2010 |
| Arthritogenic alphaviruses—an overview A Suhrbier, MC Jaffar-Bandjee, P Gasque Nature Reviews Rheumatology 8 (7), 420-429, 2012 | 551 | 2012 |
| Chikungunya virus arthritis in adult wild-type mice J Gardner, I Anraku, TT Le, T Larcher, L Major, P Roques, WA Schroder, ... Journal of virology 84 (16), 8021-8032, 2010 | 471 | 2010 |
| Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. VP Argaet, CW Schmidt, SR Burrows, SL Silins, MG Kurilla, DL Doolan, ... The Journal of experimental medicine 180 (6), 2335-2340, 1994 | 338 | 1994 |
| Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death SM Ogbourne, A Suhrbier, B Jones, SJ Cozzi, GM Boyle, M Morris, ... Cancer Research 64 (8), 2833-2839, 2004 | 319 | 2004 |
| A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses DC Jackson, YF Lau, T Le, A Suhrbier, G Deliyannis, C Cheers, C Smith, ... Proceedings of the National Academy of Sciences 101 (43), 15440-15445, 2004 | 307 | 2004 |
| Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling JJ Fros, WJ Liu, NA Prow, C Geertsema, M Ligtenberg, ... Journal of virology 84 (20), 10877-10887, 2010 | 293 | 2010 |
| Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination SA Thomson, MA Sherritt, J Medveczky, SL Elliott, DJ Moss, ... The Journal of Immunology 160 (4), 1717-1723, 1998 | 249 | 1998 |
| H‐2 class I knockout, HLA‐A2. 1‐transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies H Firat, F Garcia‐Pons, S Tourdot, S Pascolo, A Scardino, Z Garcia, ... European journal of immunology 29 (10), 3112-3121, 1999 | 239 | 1999 |
| Nanopatch‐targeted skin vaccination against West Nile virus and chikungunya virus in mice TW Prow, X Chen, NA Prow, GJP Fernando, CSE Tan, AP Raphael, ... Small 6 (16), 1776-1784, 2010 | 218 | 2010 |
| Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate JM Challacombe, A Suhrbier, PG Parsons, B Jones, P Hampson, ... The Journal of Immunology 177 (11), 8123-8132, 2006 | 207 | 2006 |
| Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock PA Rudd, J Wilson, J Gardner, T Larcher, C Babarit, TT Le, I Anraku, ... Journal of virology 86 (18), 9888-9898, 2012 | 206 | 2012 |
| Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. SA Thomson, R Khanna, J Gardner, SR Burrows, B Coupar, DJ Moss, ... Proceedings of the National Academy of Sciences 92 (13), 5845-5849, 1995 | 201 | 1995 |
| Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses A Suhrbier, M La Linn Current opinion in rheumatology 16 (4), 374-379, 2004 | 198 | 2004 |
| Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production BJ Johnson, TTT Le, CA Dobbin, T Banovic, CB Howard, FML Flores, ... Journal of Biological Chemistry 280 (6), 4037-4047, 2005 | 192 | 2005 |
| Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection YS Poo, PA Rudd, J Gardner, JAC Wilson, T Larcher, MA Colle, TT Le, ... PLoS neglected tropical diseases 8 (12), e3354, 2014 | 188 | 2014 |
| Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. SA Thomson, SL Elliott, MA Sherritt, KW Sproat, BE Coupar, AA Scalzo, ... Journal of immunology (Baltimore, Md.: 1950) 157 (2), 822-826, 1996 | 182 | 1996 |
| Effective chikungunya virus-like particle vaccine produced in insect cells SW Metz, J Gardner, C Geertsema, TT Le, L Goh, JM Vlak, A Suhrbier, ... PLoS neglected tropical diseases 7 (3), e2124, 2013 | 175 | 2013 |
| Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis SL Elliott, A Suhrbier, JJ Miles, G Lawrence, SJ Pye, TT Le, ... Journal of virology 82 (3), 1448-1457, 2008 | 174 | 2008 |
| Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus BA Lidbury, NE Rulli, A Suhrbier, PN Smith, SR McColl, AL Cunningham, ... The Journal of infectious diseases 197 (11), 1585-1593, 2008 | 172 | 2008 |